NIAID Seeks Applicants to Lead CTUs for HIV/AIDS Networks

The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting applications from U.S. and overseas research institutions seeking to become Clinical Trials Units (CTUs) in the Institute's revamped HIV/AIDS Clinical Trials Networks.

NIAID, part of the NIH, supports the world's largest portfolio of clinical research in HIV/AIDS prevention, vaccine and treatment research and development.

This solicitation, the second of two requests for applications (RFAs), is designed to increase the efficiency, accountability and integration of NIAID's HIV/AIDS clinical research networks and enhance their capacity to effectively conduct vital clinical research, especially in resource-limited settings.

Any public or private institution or organization, for-profit or nonprofit, can submit an application in response to the Clinical Trials Units RFA. These organizations, which can be domestic or foreign, may include universities, colleges, hospitals, private and group medical practices, units of state and local government, eligible agencies of the U.S. federal government and non-governmental agencies.

Four pre-application meetings devoted to a comprehensive overview of application submission requirements for the Clinical Trials Units RFA will take place at venues in the U.S. and abroad.

Copies of the RFA for Clinical Trials Units for HIV/AIDS Clinical Trials Networks and information on the locations, logistics and other details of the preapplication meetings can be obtained at http://www.niaid.nih.gov/daids/rfa/network06 (http://www.niaid.nih.gov/daids/rfa/network06).